Literature DB >> 11389629

Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution.

K M Davies1, D A Wink, J E Saavedra, L K Keefer.   

Abstract

Diazeniumdiolate ions of structure R(2)N[N(O)NO](-) (1) are of pharmacological interest because they spontaneously generate the natural bioregulatory species, nitric oxide (NO), when dissolved in aqueous media. Here we report the kinetic details for four representative reactivity patterns: (a) straightforward dissociation of the otherwise unfunctionalized diethylamine derivative 2 (anion 1, where R = Et) to diethylamine and NO; (b) results for the zwitterionic piperazin-1-yl analogue 4, for which the protonation state of the neighboring basic amine site is an important determinant of dissociation rate; (c) data for 5, a diazeniumdiolate derived from the polyamine spermine, whose complex rate equation can include terms for a variety of medium effects; and (d) the outcome for triamine 6 (R = CH(2)CH(2)NH(3)(+)), the most stable structure 1 ion identified to date. All of these dissociations are acid-catalyzed, with equilibrium protonation of the substrate preceding release of NO. Specific rate constants and pK(a) values for 2-6 have been determined from pH/rate profiles. Additionally, a hypsochromic shift (from approximately 250 to approximately 230 nm) was observed on acidifying these ions, allowing determination of a separate pK(a) for each substrate. For 6, the pK(a) value obtained kinetically was 2-3 pK(a) units higher than the value obtained from the spectral shift. Comparison of the ultraviolet spectra for 6 at various pH values with those for O- and N-alkylated diazeniumdiolates suggests that protonation at the R(2)N nitrogen initiates dissociation to NO at physiological pH, with a second protonation (at oxygen) accounting for both the spectral change and the enhanced dissociation rate at pH <4. Our results help to explain the previously noted variability in dissociation rate of 5, whose half-life we found to increase by an order of magnitude when its concentration was raised from near-zero to 1 mM, and provide mechanistic insight into the factors that govern dissociation rates among diazeniumdiolates of importance as pharmacologic progenitors of NO.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389629     DOI: 10.1021/ja002899q

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  45 in total

Review 1.  Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.

Authors:  Scott P Nichols; Wesley L Storm; Ahyeon Koh; Mark H Schoenfisch
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

2.  The effect of nitric oxide surface flux on the foreign body response to subcutaneous implants.

Authors:  Scott P Nichols; Ahyeon Koh; Nga L Brown; Michael B Rose; Bin Sun; Danielle L Slomberg; Daniel A Riccio; Bruce Klitzman; Mark H Schoenfisch
Journal:  Biomaterials       Date:  2012-06-27       Impact factor: 12.479

3.  Antibiofilm Efficacy of Nitric Oxide-Releasing Alginates against Cystic Fibrosis Bacterial Pathogens.

Authors:  Mona Jasmine R Ahonen; Jamie M Dorrier; Mark H Schoenfisch
Journal:  ACS Infect Dis       Date:  2019-06-11       Impact factor: 5.084

4.  Preparation and characterization of diazeniumdiolate releasing ethylcellulose films.

Authors:  Ajun Wan; Qun Gao; Huili Li
Journal:  J Mater Sci Mater Med       Date:  2008-09-20       Impact factor: 3.896

5.  NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay.

Authors:  Lisa A Ridnour; Robert Y S Cheng; Jonathan M Weiss; Sukhbir Kaur; David R Soto-Pantoja; Debashree Basudhar; Julie L Heinecke; C Andrew Stewart; William DeGraff; Anastasia L Sowers; Angela Thetford; Aparna H Kesarwala; David D Roberts; Howard A Young; James B Mitchell; Giorgio Trinchieri; Robert H Wiltrout; David A Wink
Journal:  Cancer Res       Date:  2015-05-19       Impact factor: 12.701

6.  Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as safe anti-inflammatory, analgesic, antipyretic, antioxidant prodrugs.

Authors:  Mitali Chattopadhyay; Carlos A Velazquez; April Pruski; Kamran V Nia; Khaled R Abdellatif; Larry K Keefer; Khosrow Kashfi
Journal:  J Pharmacol Exp Ther       Date:  2010-08-02       Impact factor: 4.030

7.  Hemocompatibility Comparison of Biomedical Grade Polymers Using Rabbit Thrombogenicity Model for Preparing Nonthrombogenic Nitric Oxide Releasing Surfaces.

Authors:  Hitesh Handa; Terry C Major; Elizabeth J Brisbois; Kagya A Amoako; Mark E Meyerhoff; Robert H Bartlett
Journal:  J Mater Chem B       Date:  2014-02-28       Impact factor: 6.331

Review 8.  Biocompatible materials for continuous glucose monitoring devices.

Authors:  Scott P Nichols; Ahyeon Koh; Wesley L Storm; Jae Ho Shin; Mark H Schoenfisch
Journal:  Chem Rev       Date:  2013-02-07       Impact factor: 60.622

9.  Diazeniumdiolate-doped poly(lactic-co-glycolic acid)-based nitric oxide releasing films as antibiofilm coatings.

Authors:  Wenyi Cai; Jianfeng Wu; Chuanwu Xi; Mark E Meyerhoff
Journal:  Biomaterials       Date:  2012-07-28       Impact factor: 12.479

Review 10.  Nitric oxide-releasing/generating polymers for the development of implantable chemical sensors with enhanced biocompatibility.

Authors:  Yiduo Wu; Mark E Meyerhoff
Journal:  Talanta       Date:  2007-06-28       Impact factor: 6.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.